Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Newsletter subscription
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Search results for "dosing"
Home
GC Wellbeing’s Laennec Injection Clears Phase 3 Hurdle for IV Drip Use, Boosting Growth Prospects
GC Wellbeing announced on June 16 that it has secured topline results demonstrating that its chronic liver disease treatment, Laennec Injection,...
06/17/2026, 22:48 ET
New Blood Test Accurately Predicts Alzheimer’s Progression, Pinpointing Optimal Candidates for Treatment
Dementia medications do not yield uniform results for every patient; instead, their clinical efficacy depends heavily on a distinct "optimal...
06/11/2026, 07:43 ET
Reengineering Your Morning Routine: The Biological Case for Water, Breakfast, and Coffee
What is the very first thing you do when you open your eyes in the morning? While the habit has fortunately declined,...
06/08/2026, 04:30 ET
Hanmi Pharm Revives 'LAPSCOVERY' Momentum with $1.26B Eli Lilly Licensing Deal
Hanmi Pharmaceutical has licensed its novel drug candidate sonefpeglutide to global pharmaceutical giant Eli Lilly and...
06/04/2026, 05:09 ET
The Cost of Over-Supplementing: How Everyday Pills Can Quietly Damage Liver and Kidneys
Many people take a cocktail of medications, vitamins, and dietary supplements daily, hoping to safeguard their health.
05/31/2026, 09:53 ET
Can Eye Health Be Reversed?... Clues Found to ‘Retinal Rejuvenation’
A potential way to return aged cells in the eye to a more youthful state has been identified.
05/21/2026, 22:00 ET
Daewoong Pharmaceutical Moves to Develop Once-Monthly GLP-1 Obesity Injection
Daewoong Pharmaceutical is teaming up with a biotech startup to develop an obesity treatment administered by injection...
05/12/2026, 05:17 ET
Vabysmo Prefilled Syringe Gains Reimbursement, Expanding Retina Treatment Options
Injectable therapies for chronic eye diseases are entering a new era where clinicians and patients can select...
04/01/2026, 21:04 ET
Alteogen to Present Subcutaneous ADC Formulation Research at International Forum in June
Alteogen announced on the 23rd that it will present research results regarding subcutaneous dosing for antibody-drug...
03/24/2026, 02:47 ET
Celltrion Secures Canadian Approval for ‘Steqeyma’ Autoinjector Formulation
Celltrion announced on March 20, 2026, that it has received additional approval from Health Canada for the autoinjector...
03/23/2026, 02:59 ET
Previous
1
2
3
Next
Languages
ENGLISH
English (US)
ASIAN
Монгол
日本語
Tiếng Việt
Bahasa Indonesia
中文 (简体, 中国大陆)
EUROPEAN
Русский
Español (España)
Français (France)
MIDDLE_EAST_AFRICA
العربية